发明名称 |
Method for prophylactic treatment of alzheimer's disease using inhibitors of glutaminyl cyclase and glutamate cyclases |
摘要 |
Provided herein are methods for treating and preventing neurodegenerative disease in a mammal by administering an inhibitor of glutaminyl cyclase (QC). Neurodegenerative diseases treatable or preventable according to methods described herein include mild cognitive impairment (MCI), Alzheimer's disease, neurodegeneration in Down Syndrome, Familial British Dementia, and Familial Danish Dementia. |
申请公布号 |
US8809010(B2) |
申请公布日期 |
2014.08.19 |
申请号 |
US200912506823 |
申请日期 |
2009.07.21 |
申请人 |
Probiodrug AG |
发明人 |
Hoffmann Torsten;Schilling Stephan;Niestroj Andre J.;Demuth Hans-Ulrich;Heiser Ulrich;Buchholz Mirko |
分类号 |
C12Q1/34 |
主分类号 |
C12Q1/34 |
代理机构 |
Dentons US LLP |
代理人 |
Dentons US LLP |
主权项 |
1. A method of prophylactically treating Alzheimer's disease in a mammal, comprising
administering to a mammalian subject a therapeutically effective amount of at least one inhibitor of glutaminyl cyclase (QC) for specifically inhibiting conversion of N-terminal glutamic acid or glutamine residues to pyroglutamyl residues in at least one QC-substrate, wherein,
the QC-inhibitor is a selective competitive QC-inhibitor; andsaid competitive QC-inhibitor inhibits glutaminyl cyclase with a Ki of 10 μM or less. |
地址 |
Halle (Saale) DE |